Xilio Therapeutics
37 hedge funds and large institutions have $25.4M invested in Xilio Therapeutics in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
37
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$4.44M | |
| 2 | +$3M | |
| 3 | +$2.11M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$1.6M |
| 5 |
SC
Stempoint Capital
New York
|
+$1.52M |
Top Sellers
| 1 | -$277K | |
| 2 | -$210K | |
| 3 | -$168K | |
| 4 |
Morgan Stanley
New York
|
-$91.6K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$44.1K |
